# PEG-IFN in HBV Patients With Incomplete Response to NA

> **NCT00883844** · PHASE4 · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 11 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Nucleos(t)ide analogue treatment with a peginterferon add-on strategy
- **DRUG:** Nucleos(t)ide analogue treatment

## Key facts

- **NCT ID:** NCT00883844
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-08
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2013-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883844, "PEG-IFN in HBV Patients With Incomplete Response to NA". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00883844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*